Moreover, specific synthetic PAR2-activating peptides, used in our study, do not affect hemagglutinin maturation but reportedly serve as important tools for investigating the role of PAR2 activation in a wide range of anti-influenza responses. The gene discussed is F2RL1; the disease is influenza.